196 related articles for article (PubMed ID: 23206294)
1. Infant and childhood neurodevelopmental outcomes following prenatal exposure to selective serotonin reuptake inhibitors: overview and design of a Finnish Register-Based Study (FinESSI).
Malm H; Artama M; Brown AS; Gissler M; Gyllenberg D; Hinkka-Yli-Salomäki S; McKeague I; Sourander A
BMC Psychiatry; 2012 Dec; 12():217. PubMed ID: 23206294
[TBL] [Abstract][Full Text] [Related]
2. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A
JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704
[TBL] [Abstract][Full Text] [Related]
3. Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study.
Malm H; Brown AS; Gissler M; Gyllenberg D; Hinkka-Yli-Salomäki S; McKeague IW; Weissman M; Wickramaratne P; Artama M; Gingrich JA; Sourander A
J Am Acad Child Adolesc Psychiatry; 2016 May; 55(5):359-66. PubMed ID: 27126849
[TBL] [Abstract][Full Text] [Related]
4. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
Singal D; Brownell M; Chateau D; Ruth C; Katz LY
BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy Complications Following Prenatal Exposure to SSRIs or Maternal Psychiatric Disorders: Results From Population-Based National Register Data.
Malm H; Sourander A; Gissler M; Gyllenberg D; Hinkka-Yli-Salomäki S; McKeague IW; Artama M; Brown AS
Am J Psychiatry; 2015 Dec; 172(12):1224-32. PubMed ID: 26238606
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
7. Maternal SSRI use during pregnancy and offspring depression or anxiety disorders: A review of the literature and description of a study protocol for a register-based cohort study.
Upadhyaya S; Brown A; Cheslack-Postava K; Gissler M; Gyllenberg D; Heinonen E; Laitinen J; McKeague I; Hinkka-Yli-Salomäki S; Sourander A; Tornio A; Malm H
Reprod Toxicol; 2023 Jun; 118():108365. PubMed ID: 36958464
[TBL] [Abstract][Full Text] [Related]
8. Prenatal Antidepressant Exposure and Offspring Brain Morphologic Trajectory.
Koc D; Tiemeier H; Stricker BH; Muetzel RL; Hillegers M; El Marroun H
JAMA Psychiatry; 2023 Dec; 80(12):1208-1217. PubMed ID: 37647036
[TBL] [Abstract][Full Text] [Related]
9. Motor development in children prenatally exposed to selective serotonin reuptake inhibitors: a large population-based pregnancy cohort study.
Handal M; Skurtveit S; Furu K; Hernandez-Diaz S; Skovlund E; Nystad W; Selmer R
BJOG; 2016 Nov; 123(12):1908-1917. PubMed ID: 26374234
[TBL] [Abstract][Full Text] [Related]
10. Risks associated with selective serotonin reuptake inhibitors in pregnancy.
Malm H; Klaukka T; Neuvonen PJ
Obstet Gynecol; 2005 Dec; 106(6):1289-96. PubMed ID: 16319254
[TBL] [Abstract][Full Text] [Related]
11. Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age.
Grzeskowiak LE; Gilbert AL; Sørensen TI; Olsen J; Sørensen HT; Pedersen LH; Morrison JL
Ann Epidemiol; 2013 Nov; 23(11):681-7. PubMed ID: 24113367
[TBL] [Abstract][Full Text] [Related]
12. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
[TBL] [Abstract][Full Text] [Related]
13. Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.
Colvin L; Slack-Smith L; Stanley FJ; Bower C
CNS Drugs; 2012 Jul; 26(7):e1-14. PubMed ID: 22712699
[TBL] [Abstract][Full Text] [Related]
14. Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors.
Grzeskowiak LE; Gilbert AL; Morrison JL
J Clin Psychopharmacol; 2012 Oct; 32(5):615-21. PubMed ID: 22926594
[TBL] [Abstract][Full Text] [Related]
15. Associations Between Brain Structure and Connectivity in Infants and Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy.
Lugo-Candelas C; Cha J; Hong S; Bastidas V; Weissman M; Fifer WP; Myers M; Talati A; Bansal R; Peterson BS; Monk C; Gingrich JA; Posner J
JAMA Pediatr; 2018 Jun; 172(6):525-533. PubMed ID: 29630692
[TBL] [Abstract][Full Text] [Related]
16. Association of Preeclampsia and Perinatal Complications With Offspring Neurodevelopmental and Psychiatric Disorders.
Kong L; Chen X; Liang Y; Forsell Y; Gissler M; Lavebratt C
JAMA Netw Open; 2022 Jan; 5(1):e2145719. PubMed ID: 35089349
[TBL] [Abstract][Full Text] [Related]
17. Rate of Chiari I malformation in children of mothers with depression with and without prenatal SSRI exposure.
Knickmeyer RC; Meltzer-Brody S; Woolson S; Hamer RM; Smith JK; Lury K; Gilmore JH
Neuropsychopharmacology; 2014 Oct; 39(11):2611-21. PubMed ID: 24837031
[TBL] [Abstract][Full Text] [Related]
18. Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.
Bakker MK; Kölling P; van den Berg PB; de Walle HE; de Jong van den Berg LT
Br J Clin Pharmacol; 2008 Apr; 65(4):600-6. PubMed ID: 17953715
[TBL] [Abstract][Full Text] [Related]
19. Prenatal smoking exposure and the risk of psychiatric morbidity into young adulthood.
Ekblad M; Gissler M; Lehtonen L; Korkeila J
Arch Gen Psychiatry; 2010 Aug; 67(8):841-9. PubMed ID: 20679592
[TBL] [Abstract][Full Text] [Related]
20. Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study.
Wemakor A; Casson K; Garne E; Bakker M; Addor MC; Arriola L; Gatt M; Khoshnood B; Klungsoyr K; Nelen V; O'Mahoney M; Pierini A; Rissmann A; Tucker D; Boyle B; de Jong-van den Berg L; Dolk H
Eur J Epidemiol; 2015 Nov; 30(11):1187-98. PubMed ID: 26148560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
